Statistics of the Dominion of New Zealand.

Title varies slightly.

New Mexico agricultural statistics.

Mode of access: Internet.

Basic statistics for counties and metropolitan areas of New York State.

Mode of access: Internet.

Statistics. Six states of Australia and New Zealand, 1861 to 1900.

Mode of access: Internet.

An appraisal of new sources of employment and unemployment statistics /

Mode of access: Internet.

Report on the vital statistics of New Zealand.

Title varies slightly.

The United States of America, a collection of facts, dates and statistics ... To be presented to each purchaser of Watson's new map of the United States.

Mode of access: Internet.

Statistics on minorities and women : information useful for affirmative action compliance programs in New York State /

Mode of access: Internet.

The New York State Board of Mediation and its predecessors; 1886 to 1950, a compilation of facts and statistics,

typewritten copy.

History of Bedford, New-Hampshire : being statistics, compiled on the occasion of the one hundredth anniversary of the incorporation of the town, May 19th, 1850.

Compiled by Peter P. Woodbury, Thomas Savage, and William Patten, Publishing Committee.

Vital statistics of the town of Keene, New Hampshire : compiled from the town records, First Church and family records, the original Fisher record and the newspapers /

Facsimile reprint. Original imprint: Keene, N.H. : Sentinel Printing Company, 1905.

Report by the Government Statistician on the vital statistics of New South Wales.

Other slight variations in title.

Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assay

Dendritic cells (DC) from distinct DC subsets are essential contributors to normal human immune responses. Despite this, reliable assays that enable DC to be counted precisely have been slow to evolve. We have now developed a new single-platform flow cytometric assay based on TruCOUN(TM) beads and the whole blood Lyse/No-Wash protocol that allows precise counting of the CD14(-) blood DC subsets: CD11c(+)CD16(-) DC, CD11c(+)CD16(+) DC, CD123(hi) DC, CD1c(+) DC and BDCA-3(+) DC. This assay requires 50 mul of whole blood; does not rely on a hematology blood analyser for the absolute DC counts; allows DC counting in EDTA samples 24 It after collection; and is suitable for cord blood and peripheral blood. The data is highly reproducible with intra-assay and inter-assay coefficients of variation less than 3% and 11%, respectively. This assay does not produce the DC-T lymphocyte conjugates that result in DC counting abnormalities in conventional gradient-density separation procedures. Using the TruCOUNT assay, we established that absolute blood DC counts reduce with age in healthy individuals. In preliminary studies, we found a significantly lower absolute blood CD11c(+)CD16(+) DC count in stage III/IV versus stage I/II breast carcinoma patients and a lower absolute blood CD123(hi) DC count in multiple myeloma patients, compared to age-matched controls. These data indicate that scientific progress in DC counting technology will lead to the global standardization of DC counting and allow clinically meaningful data to be obtained. (C) 2003 Elsevier B.V. All rights reserved.

Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics

Registration of births, recording deaths by age, sex and cause, and calculating mortality levels and differentials are fundamental to evidence-based health policy, monitoring and evaluation. Yet few of the countries with the greatest need for these data have functioning systems to produce them despite legislation providing for the establishment and maintenance of vital registration. Sample vital registration (SVR), when applied in conjunction with validated verbal autopsy, procedures and implemented in a nationally representative sample of population clusters represents an affordable, cost-effective, and sustainable short- and medium-term solution to this problem. SVR complements other information sources by producing age-, sex-, and cause-specific mortality data that are more complete and continuous than those currently available. The tools and methods employed in an SVR system, however, are imperfect and require rigorous validation and continuous quality assurance; sampling strategies for SVR are also still evolving. Nonetheless, interest in establishing SVR is rapidly growing in Africa and Asia. Better systems for reporting and recording data on vital events will be sustainable only if developed hand-in-hand with existing health information strategies at the national and district levels; governance structures; and agendas for social research and development monitoring. If the global community wishes to have mortality measurements 5 or 10 years hence, the foundation stones of SVR must be laid today.